This week, the FDA announced that it was sending a warning letter to US Stem Cell in Florida and a California venture known as Stem Immune, linked to the Cell Surgical Network. What do both of these clinics have in common? They both use a product called stromal vascular fraction (SVF) obtained from fat. The …
Mesenchymal Stem Cell in Global market report, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share. – Agency -. The global stem cell … This Post Originally Appeared via Bing News
The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond! Modeling Glaucoma with Mutant iPSCs To assess the contribution of progressive retinal ganglion cell (RGC) degeneration to glaucoma, researchers from the lab of Iqbal Ahmad (University of Nebraska …
Stem Cell Seminars: 7 Key Questions to Ask There’s been an explosion in clinics offering stem cells for orthopedic treatments in the last few years. The most aggressive blanket major metro areas, taking out full-page ads on the front pages of major newspapers, putting on large stem cell seminars that double as high-pressure sales events. …
This weekend, we hosted an IOF level 2–3 upper-extremity and foot/ankle course in our Colorado facility. As I checked out the four rooms they had running, I realized that all of the other courses on stem cells and PRP you can take right now are but a simple survey of this topic. This brought up …
One of the most promising new fields of science and medicine is the area of cell therapies and their use in regenerative medicine. These new technologies, most of which are in early stages of development, hold significant promise for transformative and potentially curative treatments for some of humanity’s most troubling and intractable maladies. Recent advances …
The U.S. Food and Drug Administration today posted a warning letter issued to US Stem Cell Clinic of Sunrise, Florida, and its Chief Scientific Officer Kristin Comella for marketing stem cell products without FDA approval and for significant deviations from current good manufacturing practice requirements, including some that could impact the sterility of their products, …
The U.S. Food and Drug Administration took decisive action to prevent the use of a potentially dangerous and unproven treatment belonging to StemImmune Inc. in San Diego, California, and administered to patients at the California Stem Cell Treatment Centers in Rancho Mirage and Beverly Hills, California. On behalf of the FDA, on Friday, Aug. 25, …
I remember a friend of mine telling me years ago that even though I had an MD after my name, I reminded him more of a chiropractor. That was in fact a high compliment as I’ve never been a fan of the traditional “bull in the china shop” medical approach. This past week, Josh Axe, …
Xue and colleagues show that prostaglandin E1 (PGE1) inhibits the activity and self-renewal of human CML leukemic stem cells. Combination of PGE1 or an agonist for its receptor EP4 with conventional tyrosine kinase inhibitor treatment can effectively target CML leukemic stem cells and reduce leukemia growth. This Post Originally Appeared at Cell Stem Cell
Dr. Riordan gave a talk about stem cell tourism. Here he is joined by “the father of the mesenchymal stem cell”, Arnold Caplan, Phd and Dr. Priscilla Ortiz. This Post Originally Appeared at CellMedicine.com
By Doug Oliver: I’m very positive about the future role of FDA in ensuring that stem cell and related therapies are safe and effective. And, because of that, I believe now is the appointed time for both patients AND therapy providers to be intentional in helping to rewire their own perspectives and consider what it …